Clinical Research Generic Drugs Pharma Companies Regulation 
Pharmaceutical Technology
FEBRUARY 24, 2023
EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies. She also cautioned against believing that all of the problems with Europe’s medicines can be solved with regulation.
pharmaphorum
JUNE 8, 2021
Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. About the interviewee.
Expert insights. Personalized for you.
162 
Let's personalize your content